Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredient:||Hydroxycarbamide 500mg|
|New Zealand Sponsor:||Bristol-Myers Squibb (NZ) Limited|
|Manufacturer:||Corden Pharma Latina SpA, Sermoneta Latina, Italy|
Dated this 30th day of August 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).